Search results
Results from the WOW.Com Content Network
A review and meta-analysis published in Neuroscience and Biobehavioral Reviews in May 2024 highlighted the benefits that prescription drugs for ADHD can bring to brain health. The research looked ...
At high doses, prescription amphetamines, used to treat ADHD could increase a person’s risk of psychosis. Image credit: visualspace/Getty Images. This article originally appeared on Medical News ...
New research in 2025 indicates that adults diagnosed with ADHD may have a shorter lifespan compared to those without the condition. [331] The study revealed that, on average, men with ADHD lived seven years less than men without ADHD, while women with ADHD had a lifespan nine years shorter than their peers. [332]
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Most research on omega-3 fatty acids is considered to be of very poor quality with widespread methodological weaknesses. [256] [257] Zinc – Although the role of zinc in ADHD has not been elucidated, there is a small amount of limited evidence that lower tissue zinc levels may be associated with ADHD. [258]
ADDitude magazine is a quarterly consumer publication about attention deficit hyperactivity disorder (ADHD or ADD) owned and operated by WebMD, LLC in New York, NY. It contains feature and service articles about ADD, ADHD and comorbid conditions including depression, anxiety, and learning disabilities like dyslexia.
Some research suggests that people with ADHD can have difficulties with organization even after learning skills because they don't apply them consistently. So a therapist can help you stay on ...
ADHD was found more often in boys, at a rate of 2:1. [10] The most common form of ADHD was inattentive (2.95% of total population), followed by hyperactive/impulsive (2.77%), then combined (2.44%). [10] While differences in prevalence rate were found internationally, it is not clear whether this reflects true differences or changes in ...